Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
IMPORTANCE: Neuromyelitis optica (NMO) is an inflammatory disease of the optic nerves and spinal cord that leads to blindness and paralysis. Effective immunosuppression is the standard of care for relapse prevention. OBJECTIVE: To compare the relapse and treatment failure rates among patients receiv...
Auteurs principaux: | Mealy, M, Wingerchuk, D, Palace, J, Greenberg, B, Levy, M |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2014
|
Documents similaires
-
Treatment of Neuromyelitis Optica: Review and Recommendations.
par: Kimbrough, D, et autres
Publié: (2012) -
Treatment of neuromyelitis optica: Review and recommendations
par: Kimbrough, D, et autres
Publié: (2012) -
Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
par: Tackley, G, et autres
Publié: (2016) -
TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
par: Elsone, L, et autres
Publié: (2012) -
B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
par: Levy M, et autres
Publié: (2021-08-01)